Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Preveceutical Medical Inc (OP:PRVCF)

0.0128 UNCHANGED

Streaming Delayed Price Updated: 3:49 PM EST, Dec 23, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	0.0128
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0128
Today's Range	0.0128 - 0.0128
52wk Range	0.0037 - 0.0436
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer

August 20, 2025

Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...

Via Newsfile

BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research

August 19, 2025

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...

Via Newsfile

Performance

YTD	-31.9%	-31.9%
1 Month	-31.2%	-31.2%
3 Month	-43.1%	-43.1%
6 Month	-49.2%	-49.2%
1 Year	-32.3%	-32.3%

More News

PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting

July 09, 2025

Via Newsfile

PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

June 30, 2025

Via Newsfile

PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

June 02, 2025

Via Newsfile

PreveCeutical Welcomes Stephen Glover as Corporate Advisor

May 26, 2025

Via Newsfile

PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies

May 14, 2025

Via Newsfile

PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof

June 28, 2023

Via Newsfile

PreveCeutical Medical - Sol-Gel and Uses thereof Patent Update

May 30, 2023

Via Newsfile

PreveCeutical Medical Launches Clinical Artificial Intelligence Division

April 24, 2023

Via Newsfile

PreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Pain

April 04, 2023

Via Newsfile

PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committee

March 20, 2023

Via Newsfile

PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof

March 06, 2023

Via Newsfile

Appointment of C. Evan Ballantyne to PreveCeutical's Board of Directors

February 21, 2023

Via Newsfile

PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development

February 07, 2023

Via Newsfile

PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds

January 25, 2023

Via Newsfile

PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds

January 23, 2023

Via Newsfile

PreveCeutical - Dynorphin Peptides (Painkiller) and Uses Thereof Patent Update and Officer Update

January 17, 2023

Via Newsfile

PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals

January 12, 2023

Via Newsfile

PreveCeutical Signs Intercompany Sol-Gel License Agreement

January 09, 2023

Via Newsfile

Appointment of Sachin Nanavati to PreveCeutical's Board of Directors

September 06, 2022

Via Newsfile

PreveCeutical Files International Patent Application for Sol-Gel Cannabinoid Formulation for Antiviral Use

November 29, 2021

Via Newsfile

PreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest's Sol-Gel Technology for Delivery of Cannabinoids

November 18, 2021

Via Newsfile

PreveCeutical Files International Patent Application for its Dynorphin Peptides

July 07, 2021

Via Newsfile

PreveCeutical Provides Corporate Update

May 31, 2021

Via Newsfile

Frequently Asked Questions

Is Preveceutical Medical Inc publicly traded?

Yes, Preveceutical Medical Inc is publicly traded.

What exchange does Preveceutical Medical Inc trade on?

Preveceutical Medical Inc trades on the OTC Traded

What is the ticker symbol for Preveceutical Medical Inc?

The ticker symbol for Preveceutical Medical Inc is PRVCF on the OTC Traded

What is the current price of Preveceutical Medical Inc?

The current price of Preveceutical Medical Inc is 0.0128

When was Preveceutical Medical Inc last traded?

The last trade of Preveceutical Medical Inc was at 12/23/25 03:49 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.